Noninvasive coronary imaging for atherosclerosis in human immunodeficiency virus infection

Curr Probl Diagn Radiol. 2011 Nov-Dec;40(6):262-7. doi: 10.1067/j.cpradiol.2011.06.001.

Abstract

Coronary artery disease is increasingly recognized as an important contributor to morbidity and mortality among persons living with human immunodeficiency virus (HIV) infection. Traditional cardiovascular disease risk factors as well as aspects of HIV infection and its therapy contribute to the increased coronary artery disease observed in HIV. Advances in noninvasive imaging methodologies in both computed tomography and magnetic resonance imaging provide opportunities to evaluate coronary artery atherosclerosis in ways not possible by conventional invasive x-ray angiography. Application of these techniques may prove very useful in the study of atherosclerosis in many diseases, such as HIV.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anti-HIV Agents / administration & dosage*
  • Anti-HIV Agents / adverse effects*
  • Coronary Angiography*
  • Coronary Artery Disease / chemically induced
  • Coronary Artery Disease / diagnosis*
  • Coronary Artery Disease / etiology
  • Dideoxynucleosides / administration & dosage
  • Dideoxynucleosides / adverse effects
  • Female
  • HIV Infections / complications
  • HIV Infections / drug therapy*
  • Humans
  • Magnetic Resonance Imaging
  • Male
  • Reproducibility of Results
  • Risk Factors
  • Sensitivity and Specificity
  • Tomography, X-Ray Computed

Substances

  • Anti-HIV Agents
  • Dideoxynucleosides
  • abacavir